Fortuna Fix Inc.
Industry
- Biotechnology
- Gene Therapy, Cell Therapy
See more in Biomedtracker
Latest on Fortuna Fix Inc.
Scrip
• By Deanna Kamienski, Beth Allan, and Maureen Riordan
Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biophar
Scrip
• By Mandy Jackson
The recent $114m Series B round raised by Semma Therapeutics Inc. reflects two positive trends about the venture capital environment for biopharmaceuticals companies – both the number of companies